Credits Available: 4.50 AMA PRA Category 1 Credit™ & 4.50 MOC points

Description: Immunotherapy, which has demonstrated benefits in advanced and metastatic settings, is moving into early non-small cell lung cancer treatment, expanding options for patients with resected or resectable early-stage non-small cell lung cancer. This rapid evolution of the early NSCLC treatment landscape, while exciting, has created clinical challenges as health care providers struggle with translating these clinical trial results into real-world clinical practices in the adjuvant and neoadjuvant settings. This educational initiative establishes impactful small group interactions among oncology care providers that will, through a variety of collaborative educational experiences, help them optimize the care of their patients with early-stage NSCLC.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Assistant
Target Specialties: Oncology

Sivraj Muralikrishnan

Rutgers Cancer Institute of New Jersey
Assistant Professor of Medicine at Rutgers Robert Wood Johnson Medical School

I am currently an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School in New Jersey with a clinical practice focused on thoracic, head & neck medical oncology. Prior to this, I was an assistant professor of medicine at Geisel School of Medicine Dartmouth, where my practice was focused on general hematology and medical oncology. I completed my fellowship training at Dartmouth Hitchcock Medical Center in New Hampshire and served as the associate program director of the Hematology/Oncology fellowship program this past year. I'm interested in medical education and teaching. I hope to foster a learning environment that is collaborative and engaging so that we may all learn from one another.